A Physician Attack on the FDA—Will the Supreme Court Reduce Access to Mifepristone?
( N Engl J Med . 2024;390(6);563–567. doi: 10.1056/NEJMms2312012.) In 1965, Ms R. traveled from Denver to have a legal abortion in Japan due to concerns about an illegal US abortion being unsafe. Today, more than 80% of women who get abortions are 11 weeks pregnant or less, and as such, may legally take abortion medication (mifepristone and misoprostol pills) at home. However, options will become much more limited if the Supreme Court decides in favor of antiabortion physicians who have sued the Food and Drug Administration (FDA) to revoke its approval and regulation of mifepristone.
Authors
- Debra Malina
- Katie Watson (ORCID: https://orcid.org/0000-0003-3609-4048)
Institutions
- Northwestern University (US)
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1097/01.aoa.0001026488.05320.02
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00